Study: Cannabidiol (CBD) Shows Potential to Inhibit Growth and Biofilm Formation of Candida albicans

A recent study published in the Canadian Journal of Microbiology demonstrates that the cannabis compound cannabidiol (CBD) may effectively inhibit the growth of Candida albicans, a yeast commonly associated with infections such as oral candidiasis.

Candida Albicans.Researchers treated C. albicans with varying concentrations of CBD, ranging from 0 to 20 µg/mL, and observed a significant reduction in yeast growth.

After one exposure to 20 µg/mL of CBD, the yeast cell count decreased from 5.1 × 10⁶ cell/mL in the control group to 1.8 × 10⁶ cell/mL. A second exposure further reduced the cell count to 1.1 × 10⁶ cell/mL. The study also noted a decrease in the yeast’s ability to transition from yeast to hyphae, a key factor in infection development, dropping from 20% in the control group to just 2% with CBD treatment.
Continue reading

Washington DC Council Approves Medical Cannabis Clarification Act, Sends it to Mayor Bowser

The Washington D.C. Council has passed the Medical Cannabis Clarification Amendment Act (Council Bill 25-581), a notable update to the District’s medical cannabis framework.

The bill, approved by the full council earlier this month, was officially presented to Mayor Muriel Bowser’s today. Mayor Bowser now faces a deadline of October 31 to either sign it into law, veto it, or allow it to become law without a signature.

The proposed law would enhance enforcement measures against unlicensed cannabis businesses. Beginning in 2024, unlicensed establishments could face escalating fines starting at $10,000 for a first violation and increasing to $30,000 for subsequent offenses. The first $100,000 in collected fines will be deposited into the Litigation Support Fund, with additional revenue directed to the Medical Cannabis Social Equity Fund. The Alcoholic Beverage and Cannabis Administration (ABCA) is also granted new authority to issue cease-and-desist orders and close businesses that pose a threat to public safety.
Continue reading

Medical Cannabis May Cut Costs in Chronic Pain Treatment, Study Finds

An early economic analysis published in the journal Expert Review of Pharmacoeconomics & Outcomes Research suggests that medical marijuana could provide notable cost savings when treating chronic pain.

The study assessed the cost-effectiveness of cannabis-based medicinal products (CBMPs) compared to other treatment options, such as analgesics, physiotherapy, and cognitive behavioral therapy, over a one-year period in the UK.

The research modeled various scenarios and consistently found that when CBMPs were used to reduce pain levels, healthcare resource usage decreased. Even with a conservative estimate of a 5% increase in efficacy, based on Real-World Evidence, CBMPs were shown to be more cost-effective. The study further predicts that as prescription costs for CBMPs decline, the potential savings will grow even larger.
Continue reading

New Jersey Launches Free Cannabis Training Academy

The New Jersey Department of State’s New Jersey Business Action Center (NJBAC), with designation and support from the New Jersey Cannabis Regulatory Commission (CRC), has launched the Cannabis Training Academy (CTA).

The CTA was officially launched yesterday, October 16. This no-cost, online cannabis educational platform aids and educates current and aspiring cannabis business owners as they navigate the process of establishing a licensed and regulatory-compliant cannabis business in New Jersey.

Participants in this comprehensive, learner-led program will receive information covering the licensing application process, municipal approval, zoning issues, raising capital, post-licensing topics and general operations. Conditional conversion support will also be available.
Continue reading

Medical Marijuana Sales in Germany Set to Surpass €420 Million in 2024, Expected to Reach €1 Billion by 2028

Medical marijuana sales in Germany are projected to surpass €420 million (about $455.2 million) in 2024, with the market on track to hit €1 billion by 2028, according to the German Cannabis Report from Prohibition Partners, a London-based data firm.

The report highlights a 30% rise in medical marijuana sales in state-licensed pharmacies during the third quarter of 2023, with further growth following new laws implemented in April. Germany’s marijuana regulations, which allow for medical use and home growing of recreational marijuana, are some of the most progressive in Europe.

Since legalizing medical marijuana in 2017, Germany now has over 200,000 patients, and physicians can prescribe marijuana for any condition they deem appropriate. The country’s public health care system also reimburses patients for marijuana obtained from pharmacies.
Continue reading

Michigan Senate Approves Bill to Lower Age to Work and Volunteer at Marijuana Businesses to 19

Michigan’s full Senate has approved Senate Bill 807 through its second reading.

(Photo credit: The Associated Press).

Filed by Senator Sean McCann in April, Senate Bill 807 was approved yesterday by the full Senate. This vote allows the measure to advance to a third and final reading. The vote comes roughly a month after the measure was passed through the Committee On Regulatory Affairs.

The proposed law “would amend the Michigan Regulation and Taxation of Marihuana Act to allow an individual who was 19 years old or older to work or volunteer for a marihuana establishment or tribal marihuana business if the individual were supervised by an agent of the establishment or business who was 21 years old or older.”
Continue reading

Nearly $160 Million in Legal Marijuana Sold in Illinois in September, Prices Reach All-Time Lows

In September, Illinois saw marijuana sales above $150 million for the 12th consecutive month.

According to updated numbers provided by the Illinois Cannabis Regulation Oversight Officer, there was $136.5 worth of recreational marijuana sold in September, in addition to $21.7 million worth of medical marijuana. The combined $158.2 million is a noticable dip from the $165 million sold last month and last September. Still, the state’s legal marijuana industry has continued to remain consistent, with monthy sales above $150 million since September 2023.

Of the recreational marijuana sold in September, $106.1 million was purchased by those living in Illinois, with out-of-state residents purchasing $30.4 million worth of marijuana and marijuana products during the same period.
Continue reading

Kamala Harris Campaign Pledges To Work With Congress To Legalize Marijuana at the Federal Level

The campaign for Vice President Kamala Harris, the Democratic nominee for president, released a policy agenda this week that includes a pledge to “legalize marijuana at the federal level.”

Harris promises to “work with Congress to ensure that the safe cultivation, distribution, and possession of recreational marijuana is the law of the land” if elected next month. This pledge comes nearly two weeks after Harris said in an interview, “I just think we have come to a point where we have to understand that we need to legalize [marijuana] and stop criminalizing this behavior.”
Continue reading

Here’s the Most Popular Marijuana Strains in North Carolina As of October 2024

Marijuana remains illegal in North Carolina, yet many strains remain popular among consumers across the state.

Tahoe OG.

Despite the prohibition, residents turn to nearby states with legal markets, online sources, and the black market to access their favorite strains. Here, we explore the most popular strains that are in demand in North Carolina as of October 2024, using data provided by our readers as well as Leafly.
Continue reading

Delaware Governor Signs Bill Allowing Marijuana Banking

Legislation to protect banks and other financial institutions that provide services to state-legal marijuana businesses has been signed into law by Governor John Carney.

House Bill 355, sponsored by Representative Ed Osienski and Senator Trey Paradee, clarifies that providing financial services to legal cannabis businesses is lawful under Delaware state law. Passage of the bill removes a major barrier for the cannabis industry, which has struggled to access traditional banking services due to the continued federal classification of marijuana as a Schedule I drug.

“This legislation is a critical step forward for Delaware’s cannabis industry,” said State Treasurer Colleen Davis. “By ensuring safe access to banking services, we are empowering legitimate businesses to operate transparently and securely.”
Continue reading